PEAK6 Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

PEAK6 Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,435	Closed	-$1.09M	–	5735
2014 Q4	$855K	Buy	7,435 +220	+3%	+$26.6K	0.01%	2083
2014 Q3	$1.13M	Sell	7,215 -4,797	-40%	-$695K	0.01%	1712
2014 Q2	$1.48M	Sell	12,012 -3,700	-24%	-$409K	0.01%	1304
2014 Q1	$1.63M	Buy	15,712 +10,212	+186%	+$1.05M	0.01%	1431
2013 Q4	$495K	Buy	+5,500	New	+$439K	﹤0.01%	2675

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

PEAK6 Group's SLXP Position: Q1 2015 in Review

PEAK6 Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 7,435 shares — an estimated $1.09M sold.

PEAK6 Group first reported a position in SLXP in Q4 2013 and held it in 5 quarters. The position peaked at $1.63M in Q1 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

PEAK6 Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
PEAK6 Group sold 7,435 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $1.09M.
PEAK6 Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 5 quarters.
PEAK6 Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.63M in Q1 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on PEAK6 Group's 13F filing for Q1 2015, filed 13 May 2015.